A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/15/2006	EP1720579A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances
11/15/2006	EP1720578A2 Bacteriostatic esters for topical use
11/15/2006	EP1720577A2 Ciclesonide and glycopyrronium combination
11/15/2006	EP1720576A1 Photodynamic therapy for the treatment of acne
11/15/2006	EP1720574A1 Method of treating abnormal cell growth using c-met and-tor inhibitors
11/15/2006	EP1720568A2 Immunostimulatory viral rna oligonucleotides
11/15/2006	EP1720565A1 Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof
11/15/2006	EP1720563A2 Methods and compositions for the treatment of inflammation
11/15/2006	EP1720558A1 Composition and method for use in cartilage affecting conditions
11/15/2006	EP1720557A2 Rapidly disintegrating taste-masked tablet
11/15/2006	EP1720556A2 Novel 2'-c-methyl nucleoside derivatives
11/15/2006	EP1720555A1 Tetracycline derivatives for the treatment of ocular pathologies
11/15/2006	EP1720554A1 Use of meloxicam for the treatment of respiratory diseases in pigs
11/15/2006	EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1720551A1 Alkaloid formulations
11/15/2006	EP1720550A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720549A1 Kv1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency
11/15/2006	EP1720548A1 Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
11/15/2006	EP1720547A1 Use of gaboxadol for treating insomnia
11/15/2006	EP1720546A1 Novel, sustained-action beta-2-agonists and their use as medicaments
11/15/2006	EP1720545A1 Bicyclic and bridged nitrogen heterocycles
11/15/2006	EP1720544A1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
11/15/2006	EP1720543A1 Roflumilast and glycopryrronium combination
11/15/2006	EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006	EP1720541A1 Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
11/15/2006	EP1720540A2 Methods for treating resistant or refractory tumors
11/15/2006	EP1720539A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
11/15/2006	EP1720538A1 Method for inducing cell death with carbonyl scavengers
11/15/2006	EP1720537A2 Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
11/15/2006	EP1720536A1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
11/15/2006	EP1720535A1 Treating or preventing diabetes with cannabidiol
11/15/2006	EP1720534A1 Method and composition for burned skin
11/15/2006	EP1720533A2 Amoxicillin instant granulate
11/15/2006	EP1720532A1 Controlled release formulations
11/15/2006	EP1720531A2 New compositions containing quinoline compounds
11/15/2006	EP1720530A2 Screening method for emulators of neural activity and digestive system using gpr35
11/15/2006	EP1720527A2 A stable pharmaceutical composition comprising an acid labile drug
11/15/2006	EP1720526A1 Coated conditioners for use in foods and pharmaceuticals
11/15/2006	EP1720524A2 Extended release tablets of clarithromycin
11/15/2006	EP1720523A2 Cyclosporin formulations
11/15/2006	EP1720520A2 Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
11/15/2006	EP1720518A1 Alginate viscoelastic composition, method of use and package
11/15/2006	EP1720516A2 Expandable gastric retention device
11/15/2006	EP1720498A2 Abuse potential reduction in abusable substance dosage form
11/15/2006	EP1720410A1 Compositions and methods for the treatment and clinical remission of psoriasis
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1648868B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
11/15/2006	EP1646391B1 Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain
11/15/2006	EP1646387B1 Use of indazole derivatives for the treatment of neuropathic pain
11/15/2006	EP1633334B1 Topical administration of vasoactive vitamin b3 compounds for promoting sleep
11/15/2006	EP1599198B1 Potassium taurate bicarbonate and ascorbate complexes
11/15/2006	EP1572175B1 Formulation, which can be administered gastrointestinally, containing green tea extract and an no donor
11/15/2006	EP1562945B1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
11/15/2006	EP1562907B1 Pyridine derivatives as cb2 receptor modulators
11/15/2006	EP1539746B1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
11/15/2006	EP1513800B1 N-benzoylureidocinnamate derivatives, method for production and use thereof
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1492519B1 Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006	EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006	EP1450799B1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/15/2006	EP1427733B1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1416927B1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1407014B1 Screening method for attenuating or virulence defective microbial cells
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1399143B1 Use of acetyl l-carnitine for the preparation of a medication to treat anhedonia
11/15/2006	EP1392692B1 (oxo-pyrazolo¬1,5a\|pyrimidin-2-yl)alkyl-carboxamides
11/15/2006	EP1389092B1 Abuse-resistant opioid dosage form
11/15/2006	EP1363925B1 Macrolide antibiotics
11/15/2006	EP1363648B1 Agastache rugosa extract having anti-inflammatory activity and anti-atherogenic activity
11/15/2006	EP1353968B1 Linear block copolymer
11/15/2006	EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/15/2006	EP1335919B1 Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents
11/15/2006	EP1326610B1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1309557B9 Amlodipine hemimaleate
11/15/2006	EP1309323B1 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives
11/15/2006	EP1272197B1 Combination of lecithin with ascorbic acid
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1244679B1 Purine derivatives
11/15/2006	EP1152731B1 A skin care composition that mediates cell to cell communication
11/15/2006	EP1142885B1 2-(n-cyanoimino)thiazolidin-4-one derivatives
11/15/2006	EP1100489B8 Method of altering nutritional components of milk produced by a lactating animal
11/15/2006	EP1093363B1 Compositions for treatment of disorders associated with chlamydia
11/15/2006	EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006	EP1019066B1 Methods and compositions for preventing and treating heartburn
11/15/2006	EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	EP0877607B1 Biphenyl compounds and use thereof as oestrogenic agents
11/15/2006	EP0873127B1 Anthelmintic macrocyclic lactone compositions
11/15/2006	EP0799032B1 Pharmacologic management of snoring

1 ... 4008 4009 4010 4011 4012 4013 4014 4015 4016 4017 4018 4019 4020 4021 4022 4023 4024 4025 4026 4027 4028 ... 7860